Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tracking the elusive prion.

Susan W Liebman1, James A Mastrianni

  • 1Department of Biological Sciences, The University of Illinois at Chicago, Chicago, IL 60670, USA. sueL@uic.edu

Trends in Molecular Medicine
|September 10, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Depleting prion protein using splice-switching small molecules.

bioRxiv : the preprint server for biology·2026
Same author

Interactions between non-prion and prion domains of Rnq1 direct formation of amyloid vs liquid-like aggregates and create transmission barriers.

bioRxiv : the preprint server for biology·2026
Same author

Bloodwork-free Early Screening for Alzheimer's Disease via Comorbid Pattern Recognition in Electronic Health Records.

Research square·2026
Same author

Deletion of the Saccharomyces cerevisiae RACK1 homolog, ASC1, enhances autophagy which mitigates TDP-43 toxicity.

Genetics·2026
Same author

Deletion of the <i>Saccharomyces cerevisiae RACK1</i> homolog, <i>ASC1</i> , enhances autophagy which mitigates TDP-43 toxicity.

bioRxiv : the preprint server for biology·2025
Same author

An adenine model of inborn metabolism errors alters TDP-43 aggregation and reduces its toxicity in yeast revealing insights into protein misfolding diseases.

Microbial cell (Graz, Austria)·2025
Same journal

Hyocholic acids: Third bile acids for neonatal health.

Trends in molecular medicine·2026
Same journal

Clonal hematopoiesis in Alzheimer's brain: Protective, pathogenic, and context-dependent?

Trends in molecular medicine·2026
Same journal

Targeting amino acid metabolism in hepatocellular carcinoma.

Trends in molecular medicine·2026
Same journal

Turning perfusion into repair through ferroptosis blockade.

Trends in molecular medicine·2026
Same journal

CaMKK2: A tumor stress-integration node.

Trends in molecular medicine·2026
Same journal

Precision gene editing: From proof-of-concept to curative therapies.

Trends in molecular medicine·2026
See all related articles

Researchers created infectious prion material in a cell-free system, a breakthrough for understanding and treating fatal neurodegenerative prion diseases.

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Protein Misfolding Diseases

Background:

  • Prion diseases are fatal, infectious neurodegenerative disorders with no current cures.
  • The infectious agent is believed to be a misfolded prion protein that induces normal proteins to misfold.
  • Generating infectious prions in vitro has been a significant challenge, hindering research.

Purpose of the Study:

  • To overcome the inability to generate infectious prion material in vitro.
  • To establish a cell-free system for prion propagation.
  • To pave the way for developing diagnostics and therapeutics for prion diseases.

Main Methods:

  • Development of a novel cell-free system for prion propagation.
  • Utilized cell lysate rather than purified proteins for prion seeding.

Related Experiment Videos

Main Results:

  • Successfully generated infectious prion material in a cell-free system.
  • Demonstrated the feasibility of in vitro prion formation using cell lysate.

Conclusions:

  • The cell-free system represents a significant advancement in prion disease research.
  • This system will facilitate the study of prion conversion mechanisms.
  • Opens avenues for identifying therapeutic targets and developing diagnostic tools for prion diseases.